Benjamin F. Edwards & Company, Inc. Vertex Pharmaceuticals Inc Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 5,892 shares of VRTX stock, worth $2.63 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,892

Previous 4,960 18.79%

Holding current value

$2.63 Million

Previous $2.07 Million 33.19%

% of portfolio

0.05%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $366,098 - $452,513	932 Added 18.79%	5,892 $2.76 Million
Q1 2024 Apr 29, 2024	BUY	$407.69 - $446.08 $525,104 - $574,551	1,288 Added 35.08%	4,960 $2.07 Million
Q4 2023 Feb 06, 2024	BUY	$343.0 - $410.68 $294,637 - $352,774	859 Added 30.54%	3,672 $1.49 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $42,610 - $45,669	126 Added 4.69%	2,813 $978,000
Q2 2023 Aug 15, 2023	BUY	$314.42 - $351.91 $31,127 - $34,839	99 Added 3.83%	2,687 $946,000
Q1 2023 Apr 27, 2023	SELL	$283.23 - $323.1 $27,190 - $31,017	-96 Reduced 3.58%	2,588 $815,000
Q3 2022 Oct 28, 2022	SELL	$273.83 - $305.53 $547 - $611	-2 Reduced 0.07%	2,684 $777,000
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $140,506 - $174,944	-598 Reduced 18.21%	2,686 $757,000
Q4 2021 Feb 07, 2022	BUY	$177.01 - $223.45 $106,206 - $134,070	600 Added 22.35%	3,284 $721,000
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $150,366 - $177,322	-802 Reduced 23.01%	2,684 $541,000
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $17,803 - $20,752	86 Added 2.53%	3,486 $749,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $24,634 - $32,854	119 Added 3.63%	3,400 $804,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $218,580 - $259,150	-855 Reduced 20.67%	3,281 $893,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $260,880 - $342,240	1,157 Added 38.84%	4,136 $1.2 Million
Q1 2020 May 07, 2020	BUY	$199.77 - $247.81 $36,557 - $45,349	183 Added 6.55%	2,979 $709,000
Q3 2019 Nov 05, 2019	BUY	$166.23 - $187.09 $429,205 - $483,066	2,582 Added 1206.54%	2,796 $474,000
Q2 2019 Aug 08, 2019	BUY	$164.61 - $190.37 $987 - $1,142	6 Added 2.88%	214 $39,000
Q4 2018 Jan 31, 2019	BUY	$151.91 - $192.21 $6,380 - $8,072	42 Added 25.3%	208 $34,000
Q3 2018 Oct 29, 2018	BUY	$167.73 - $192.74 $9,392 - $10,793	56 Added 50.91%	166 $32,000
Q2 2018 Jul 19, 2018	BUY	$145.72 - $169.96 $1,457 - $1,699	10 Added 10.0%	110 $19,000
Q3 2017 Oct 24, 2017	BUY	$148.13 - $162.24 $14,813 - $16,224	100	100 $15,000

Others Institutions Holding VRTX

# of Institutions

1,833

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $115B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Vertex Pharmaceuticals Inc Transaction History